Published in Cell on July 21, 2000
ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res (2011) 4.91
In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature (2000) 4.38
BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol (2009) 3.79
Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc Natl Acad Sci U S A (2003) 3.37
A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes. Proc Natl Acad Sci U S A (2002) 2.78
Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol Cell Biol (2001) 2.76
Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol Cell Biol (2004) 2.67
Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J Virol (2004) 2.27
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer (2003) 2.26
The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex. Dev Cell (2007) 2.20
The BRG1 transcriptional coregulator. Nucl Recept Signal (2008) 2.00
BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol (2001) 1.96
Direct DNA binding by Brca1. Proc Natl Acad Sci U S A (2001) 1.94
Mechanisms of ATP dependent chromatin remodeling. Mutat Res (2007) 1.94
The human Nup107-160 nuclear pore subcomplex contributes to proper kinetochore functions. EMBO J (2007) 1.92
Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells. Proc Natl Acad Sci U S A (2005) 1.91
BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci U S A (2002) 1.89
Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter. EMBO J (2006) 1.87
Regulation of E2F1 by BRCT domain-containing protein TopBP1. Mol Cell Biol (2003) 1.84
Transcription activator interactions with multiple SWI/SNF subunits. Mol Cell Biol (2002) 1.82
Chl1p, a DNA helicase-like protein in budding yeast, functions in sister-chromatid cohesion. Genetics (2004) 1.76
Chromatin remodeling and histone modification in the conversion of oligodendrocyte precursors to neural stem cells. Genes Dev (2004) 1.63
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers. BMC Cancer (2007) 1.63
Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response. Mol Cell Biol (2004) 1.63
A methylation-mediator complex in hormone signaling. Genes Dev (2004) 1.61
Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Trends Mol Med (2007) 1.59
Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks. DNA Repair (Amst) (2007) 1.52
Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program. J Biol Chem (2007) 1.43
Emerging roles of BRCA1 alternative splicing. Mol Pathol (2003) 1.41
Mechanisms of BRCA1 tumor suppression. Cancer Discov (2012) 1.32
BRCA1 is a negative modulator of the PRC2 complex. EMBO J (2013) 1.31
Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex. Mol Cell Biol (2006) 1.30
BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists. EMBO J (2004) 1.29
BRCA1 haploinsufficiency for replication stress suppression in primary cells. Nat Commun (2014) 1.24
The ubiquitin E3 ligase activity of BRCA1 and its biological functions. Cell Div (2008) 1.21
The emerging roles of ARID1A in tumor suppression. Cancer Biol Ther (2014) 1.21
The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene. Mol Cell Biol (2005) 1.20
Multiple facets of histone variant H2AX: a DNA double-strand-break marker with several biological functions. Nucleic Acids Res (2015) 1.19
Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev (2004) 1.18
Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci. Mol Cell Biol (2001) 1.17
Functional assays for BRCA1 and BRCA2. Int J Biochem Cell Biol (2006) 1.15
DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status. Am J Hum Genet (2010) 1.13
Characterization of Arabidopsis thaliana ortholog of the human breast cancer susceptibility gene 1: AtBRCA1, strongly induced by gamma rays. Nucleic Acids Res (2003) 1.13
In vitro nuclear interactome of the HIV-1 Tat protein. Retrovirology (2009) 1.13
BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells. J Cell Biol (2013) 1.12
The p16(INK4A) tumor suppressor regulates cellular oxidative stress. Oncogene (2010) 1.12
Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk. Oncogene (2011) 1.12
BRCA1 recruitment to transcriptional pause sites is required for R-loop-driven DNA damage repair. Mol Cell (2015) 1.12
Versatile functions of p53 protein in multicellular organisms. Biochemistry (Mosc) (2007) 1.11
Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. Biochem J (2002) 1.10
Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability. J Biol Chem (2010) 1.10
HSP70 induction by ING proteins sensitizes cells to tumor necrosis factor alpha receptor-mediated apoptosis. Mol Cell Biol (2006) 1.09
The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a. Mol Cancer (2009) 1.06
JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction. Genes Dev (2002) 1.06
Epigenetic mechanisms of Groucho/Grg/TLE mediated transcriptional repression. Mol Cell (2011) 1.05
Multiple aspects of ATP-dependent nucleosome translocation by RSC and Mi-2 are directed by the underlying DNA sequence. PLoS One (2009) 1.04
Misbehaviour of XIST RNA in breast cancer cells. PLoS One (2009) 1.04
BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression. Nucleic Acids Res (2010) 1.02
Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene. Epigenetics (2011) 1.01
The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes. J Cell Physiol (2010) 1.01
Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma. Am J Pathol (2011) 0.99
Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas. Hum Pathol (2011) 0.99
BRG1 is a prognostic marker and potential therapeutic target in human breast cancer. PLoS One (2013) 0.98
Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells. Br J Cancer (2010) 0.98
Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications. Breast Cancer Res (2011) 0.95
BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss. Mol Cell Biol (2013) 0.95
SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy. Nucleic Acids Res (2007) 0.95
Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. Exp Cell Res (2012) 0.94
Methylation of the tumor suppressor protein, BRCA1, influences its transcriptional cofactor function. PLoS One (2010) 0.94
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1. J Clin Invest (2016) 0.94
BRCA1 associates with the inactive X chromosome in late S-phase, coupled with transient H2AX phosphorylation. Chromosoma (2005) 0.92
Somatic alterations contributing to metastasis of a castration-resistant prostate cancer. Hum Mutat (2013) 0.92
Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. PLoS Genet (2015) 0.92
A Systematic Analysis of Factors Localized to Damaged Chromatin Reveals PARP-Dependent Recruitment of Transcription Factors. Cell Rep (2015) 0.91
Chromatin remodeling and repair of DNA double-strand breaks. J Mol Histol (2006) 0.89
NF-κB is a critical mediator of BRCA1-induced chemoresistance. Oncogene (2013) 0.88
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Front Biosci (Landmark Ed) (2014) 0.88
Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers. Br J Cancer (2006) 0.87
The chromatin remodeling protein BRG1 modulates BRCA1 response to UV irradiation by regulating ATR/ATM activation. Front Oncol (2013) 0.86
Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations. PLoS One (2013) 0.86
BRCA1 at a branch point. Proc Natl Acad Sci U S A (2001) 0.86
Reconstitution of enhancer function in paternal pronuclei of one-cell mouse embryos. Mol Cell Biol (2001) 0.85
Gene clusters, molecular evolution and disease: a speculation. Curr Genomics (2009) 0.85
The BAH domain of Rsc2 is a histone H3 binding domain. Nucleic Acids Res (2013) 0.84
PI 3 kinase related kinases-independent proteolysis of BRCA1 regulates Rad51 recruitment during genotoxic stress in human cells. PLoS One (2010) 0.84
Role of BRCA1 in controlling mitotic arrest in ovarian cystadenoma cells. Int J Cancer (2011) 0.84
Association of BRCA1 with the inactive X chromosome and XIST RNA. Philos Trans R Soc Lond B Biol Sci (2004) 0.83
SNR1 (INI1/SNF5) mediates important cell growth functions of the Drosophila Brahma (SWI/SNF) chromatin remodeling complex. Genetics (2004) 0.83
BRCA1 and Oxidative Stress. Cancers (Basel) (2014) 0.83
Genome-wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co-activation. EMBO J (2014) 0.83
Mapping and conformational characterization of the DNA-binding region of the breast cancer susceptibility protein BRCA1. Biochem J (2006) 0.82
Functional interaction of SCAI with the SWI/SNF complex for transcription and tumor cell invasion. PLoS One (2013) 0.82
A seven-gene CpG-island methylation panel predicts breast cancer progression. BMC Cancer (2015) 0.82
Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin. Oncogene (2013) 0.82
The role of epigenetic transcriptional regulation in BRCA1-mediated tumor suppression. Transcription (2012) 0.81
The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. J Cell Physiol (2015) 0.81
Detoxification: a novel function of BRCA1 in tumor suppression? Toxicol Sci (2011) 0.80
ATP-dependent chromatin remodeling complexes as novel targets for cancer therapy. Adv Cancer Res (2014) 0.80
SWI/SNF complexes are required for full activation of the DNA-damage response. Oncotarget (2015) 0.80
Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers. Cancer Med (2014) 0.79
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (2001) 22.06
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell (1991) 15.76
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell (1994) 13.76
A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature (1994) 11.50
Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res (2000) 10.78
Boron nitride substrates for high-quality graphene electronics. Nat Nanotechnol (2010) 9.72
Linkage group I: the simultaneous estimation of recombination and interference. Birth Defects Orig Artic Ser (1976) 8.63
SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev (1992) 8.60
Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science (1995) 8.58
A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87
Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature (1992) 7.66
NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell (1998) 7.58
Control of memory formation through regulated expression of a CaMKII transgene. Science (1996) 7.56
Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science (1999) 7.51
The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell (1998) 7.37
Notch signaling is essential for vascular morphogenesis in mice. Genes Dev (2000) 6.88
Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke (2001) 6.61
Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science (1999) 6.38
Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J (1996) 6.36
Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature (2001) 6.36
Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev (1996) 6.01
New Ballard Score, expanded to include extremely premature infants. J Pediatr (1991) 5.82
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A (1999) 5.78
Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med (1998) 5.65
Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science (1994) 5.47
Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41
Rapid evolution of male reproductive genes in the descent of man. Nature (2000) 5.33
The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell (1996) 5.20
Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development (1995) 5.18
Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol (1994) 5.13
BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell (2001) 5.05
A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature (1994) 5.01
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med (1993) 4.99
Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell (1998) 4.95
Identification of self peptides bound to purified HLA-B27. Nature (1991) 4.88
Distinct functions of SR proteins in alternative pre-mRNA splicing. Science (1993) 4.79
The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins. Nature (1999) 4.69
Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1972) 4.64
Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke (2001) 4.64
Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology (2002) 4.45
A dust-obscured massive maximum-starburst galaxy at a redshift of 6.34. Nature (2013) 4.43
Bone development. Annu Rev Cell Dev Biol (2000) 4.24
A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev (2000) 4.23
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. Oncogene (2009) 4.10
Peptoids: a modular approach to drug discovery. Proc Natl Acad Sci U S A (1992) 4.08
Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med (2011) 4.04
Universality and structure of the N-end rule. J Biol Chem (1989) 3.97
Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature (1992) 3.85
Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature (1992) 3.82
Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proc Natl Acad Sci U S A (1998) 3.72
Cloning of a human gene encoding the general transcription initiation factor IIB. Nature (1991) 3.67
The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cell Mol Life Sci (2006) 3.62
Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription. Cell (1992) 3.62
Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry (2009) 3.56
National character does not reflect mean personality trait levels in 49 cultures. Science (2005) 3.56
Is routine indwelling catheterisation of the bladder for caesarean section necessary? A systematic review. BJOG (2010) 3.54
Ballistic 2-d imaging through scattering walls using an ultrafast optical kerr gate. Science (1991) 3.53
Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science (1995) 3.53
In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci U S A (1996) 3.53
A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature (1996) 3.50
ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature (2000) 3.48
An RNA polymerase II elongation factor encoded by the human ELL gene. Science (1996) 3.46
Interaction of poliovirus polypeptide 3CDpro with the 5' and 3' termini of the poliovirus genome. Identification of viral and cellular cofactors needed for efficient binding. J Biol Chem (1994) 3.45
Mot1, a global repressor of RNA polymerase II transcription, inhibits TBP binding to DNA by an ATP-dependent mechanism. Genes Dev (1994) 3.45
Requirement of RSF and FACT for transcription of chromatin templates in vitro. Science (1998) 3.38
Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A (2000) 3.37
Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell (2001) 3.34
Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science (1993) 3.24
Role of IRS-2 in insulin and cytokine signalling. Nature (1995) 3.23
Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage (2005) 3.21
Cloning of a yeast 8-oxoguanine DNA glycosylase reveals the existence of a base-excision DNA-repair protein superfamily. Curr Biol (1996) 3.20
The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes. Proc Natl Acad Sci U S A (2000) 3.16
The p400 complex is an essential E1A transformation target. Cell (2001) 3.05
Purification and characterization of the nuclear RNase P holoenzyme complex reveals extensive subunit overlap with RNase MRP. Genes Dev (1998) 2.97
Phosphorylation of p53 serine 15 increases interaction with CBP. J Biol Chem (1998) 2.97
Yeast global transcriptional regulators Sin4 and Rgr1 are components of mediator complex/RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A (1995) 2.96
Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS (1996) 2.95
Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med (1999) 2.92
Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci (2001) 2.84
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet (2000) 2.82
Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy. J Thromb Haemost (2006) 2.81
Direct identification of the active-site nucleophile in a DNA (cytosine-5)-methyltransferase. Biochemistry (1991) 2.77
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids. Nucleic Acids Res (1994) 2.75
NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature (2005) 2.74
Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell (1991) 2.73
Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science (1999) 2.71
Paternal population history of East Asia: sources, patterns, and microevolutionary processes. Am J Hum Genet (2001) 2.71
A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol (2000) 2.70
BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J Exp Med (2000) 2.69
Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene (2007) 2.68
ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell (1993) 2.67
The intermediate endpoint effect in logistic and probit regression. Clin Trials (2007) 2.67
Type 1 protein phosphatase acts in opposition to IpL1 protein kinase in regulating yeast chromosome segregation. Mol Cell Biol (1994) 2.59
Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood (1999) 2.59